Zydus Cadila And Bayer Extend Joint Venture By Three Years
As Bayer Zydus Pharma Continues To Operate In India
Zydus Cadila and Bayer have announced the extension of their ten-year long joint venture by three more years. The companies will continue to focus on core therapies including cardiovascular diseases, diabetes, women’s health, ophthalmology and oncology, in India.
